2013
DOI: 10.1016/j.biomaterials.2013.03.052
|View full text |Cite
|
Sign up to set email alerts
|

The promotion of bone regeneration through positive regulation of angiogenic–osteogenic coupling using microRNA-26a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
146
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 194 publications
(150 citation statements)
references
References 45 publications
3
146
0
1
Order By: Relevance
“…The use of commercial cationic lipids in biomaterial-based approaches to deliver miRNA therapeutics is exemplified by the widespread use of Lipofectamine 2000 [53][54][55][56] along with Lipofectamine RNAiMAX [57] and SiPORT NeoFx. [58] Generally, cationic lipids complex with the miRNA cassettes through electrostatic interaction, and the overall positive charge of the complex dictates the cellular uptake, although neutrally charged liposomes can also encapsulate the cargo within their core. Complexes formed by encapsulation of the miRNA cargo, as opposed to charge adsorption, are not limited to lipid-based vectors and have also shown effective delivery profiles in RM applications.…”
Section: Nonviral Vectorsmentioning
confidence: 99%
See 4 more Smart Citations
“…The use of commercial cationic lipids in biomaterial-based approaches to deliver miRNA therapeutics is exemplified by the widespread use of Lipofectamine 2000 [53][54][55][56] along with Lipofectamine RNAiMAX [57] and SiPORT NeoFx. [58] Generally, cationic lipids complex with the miRNA cassettes through electrostatic interaction, and the overall positive charge of the complex dictates the cellular uptake, although neutrally charged liposomes can also encapsulate the cargo within their core. Complexes formed by encapsulation of the miRNA cargo, as opposed to charge adsorption, are not limited to lipid-based vectors and have also shown effective delivery profiles in RM applications.…”
Section: Nonviral Vectorsmentioning
confidence: 99%
“…[102,106] Whether one of the routes may be better suited for clinical translation remains to be elucidated, although in situ transfecting scaffolds hold greater potential to exist as "off-the-shelf" products. [107] Many distinct scaffold types have been tuned to serve the purpose of miRNA delivery, including several hydrogels, [58,92,106,[108][109][110][111][112][113][114] electrospun fibers, [63,[115][116][117][118] and more prolifically porous or spongy scaffolds. [46,47,50,54,55,96,112,[119][120][121][122][123][124][125][126][127][128][129][130] Before reviewing the details of their applications, summarized in Table 2 and described further in the next section, we will discuss the key characteristics making these materials amenable to miRNA delivery.…”
Section: Scaffolds For Microrna Deliverymentioning
confidence: 99%
See 3 more Smart Citations